Symbols / BIOX Stock $0.48 -3.29% Bioceres Crop Solutions Corp.

Basic Materials • Agricultural Inputs • Argentina • NMS
BIOX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Basic Materials
Industry Agricultural Inputs
CEO Dr. Federico Trucco Ph.D.
Exch · Country NMS · Argentina
Market Cap 30.62M
Enterprise Value 305.00M
Income -56.37M
Sales 318.16M
FCF (ttm) -423.55K
Book/sh 4.20
Cash/sh 0.26
Employees 751
Insider 10d
IPO Mar 22, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E 0.75
PEG 1.04
P/S 0.10
P/B 0.11
P/C
EV/EBITDA 25.83
EV/Sales 0.96
Quick Ratio 0.62
Current Ratio 0.94
Debt/Eq 89.64
LT Debt/Eq
EPS (ttm) -1.06
EPS next Y 0.64
EPS Growth
Revenue Growth -16.40%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-05-21
Earnings (prior) 2026-03-13
ROA -0.39%
ROE -18.95%
ROIC
Gross Margin 39.42%
Oper. Margin 8.92%
Profit Margin -17.72%
Shs Outstand 63.82M
Shs Float 39.53M
Insider Own 25.54%
Instit Own 31.71%
Short Float 2.35%
Short Ratio 1.11
Short Interest 872.77K
52W High 5.17
vs 52W High -90.73%
52W Low 0.35
vs 52W Low 38.27%
Beta 0.46
Impl. Vol. 25.00%
Rel Volume 0.26
Avg Volume 868.98K
Volume 227.32K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $0.50
Price $0.48
Change -3.29%
About

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.48
Low
High
Mean

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-02 main Canaccord Genuity Hold → Hold $2
2025-11-14 main Canaccord Genuity Hold → Hold $2
2025-09-10 main Lake Street Buy → Buy $5
2025-09-10 down Canaccord Genuity Buy → Hold $3
2025-07-15 main Oppenheimer Outperform → Outperform $6
2025-04-22 main Oppenheimer Outperform → Outperform $7
2025-02-13 main Canaccord Genuity Buy → Buy $7
2025-02-07 main Lake Street Buy → Buy $8
2025-02-07 main Canaccord Genuity Buy → Buy $7
2025-01-28 main Oppenheimer Outperform → Outperform $12
2024-11-13 main Canaccord Genuity Buy → Buy $10
2024-10-21 main Oppenheimer Outperform → Outperform $13
2024-10-17 main Canaccord Genuity Buy → Buy $10
2024-09-11 main Canaccord Genuity Buy → Buy $13
2024-09-11 main Roth MKM Buy → Buy $13
2024-09-11 main Lake Street Buy → Buy $13
2024-09-11 main Oppenheimer Outperform → Outperform $16
2024-02-09 main Roth MKM Buy → Buy $21
2023-11-01 main Roth MKM Buy → Buy $20
2023-09-12 main Lake Street Buy → Buy $25
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
333.34
-28.29%
464.83
+10.82%
419.45
+27.70%
328.46
Operating Revenue
333.34
-28.29%
464.83
+10.82%
419.45
+27.70%
328.46
Cost Of Revenue
205.19
-27.34%
282.40
+17.37%
240.59
+18.12%
203.68
Reconciled Cost Of Revenue
193.60
-28.64%
271.29
+16.76%
232.34
+16.64%
199.19
Gross Profit
128.15
-29.75%
182.43
+2.00%
178.85
+43.34%
124.78
Operating Expense
128.91
-6.84%
138.38
+10.15%
125.62
+55.95%
80.56
Research And Development
14.91
-13.20%
17.18
+11.98%
15.35
+120.88%
6.95
Selling General And Administration
88.35
-6.28%
94.27
+10.20%
85.54
+49.13%
57.36
Selling And Marketing Expense
15.88
-5.59%
16.82
+9.81%
15.31
+6.58%
14.37
General And Administrative Expense
72.47
-6.43%
77.45
+10.29%
70.23
+63.36%
42.99
Salaries And Wages
47.29
-6.84%
50.77
+22.90%
41.31
+69.56%
24.36
Other Gand A
22.33
-9.10%
24.57
-5.19%
25.91
+52.37%
17.01
Other Operating Expenses
2.79
+9.18%
2.56
+23.73%
2.07
+134.09%
0.88
Total Expenses
334.11
-20.60%
420.77
+14.90%
366.22
+28.84%
284.24
Operating Income
-0.76
-101.73%
44.06
-17.23%
53.23
+20.37%
44.22
Total Operating Income As Reported
-2.24
-104.88%
45.85
-15.38%
54.18
+35.90%
39.87
EBITDA
-9.76
-117.28%
56.49
-5.42%
59.73
+56.33%
38.20
Normalized EBITDA
11.24
-82.47%
64.12
-11.36%
72.34
+51.72%
47.68
Reconciled Depreciation
22.18
+4.16%
21.30
+9.82%
19.39
+111.04%
9.19
EBIT
-31.94
-190.76%
35.19
-12.75%
40.34
+39.01%
29.02
Total Unusual Items
-21.00
-175.05%
-7.63
+39.49%
-12.62
-33.12%
-9.48
Total Unusual Items Excluding Goodwill
-21.00
-175.05%
-7.63
+39.49%
-12.62
-33.12%
-9.48
Special Income Charges
1.04
-47.53%
1.98
+322.33%
-0.89
-1924.02%
0.05
Other Special Charges
-0.41
+75.88%
-1.70
-287.08%
-0.44
+73.37%
-1.65
Restructuring And Mergern Acquisition
0.00
+100.00%
-1.03
0.00
Write Off
7.12
+845.51%
0.75
-43.24%
1.33
-16.94%
1.60
Net Income
-55.42
-1396.07%
4.28
-77.23%
18.78
+360.85%
-7.20
Pretax Income
-57.57
-620.18%
11.07
-42.07%
19.11
+35.85%
14.06
Net Non Operating Interest Income Expense
-33.71
-25.44%
-26.87
-12.96%
-23.79
-32.70%
-17.93
Interest Expense Non Operating
25.63
+6.24%
24.12
+13.64%
21.23
+41.98%
14.95
Net Interest Income
-33.71
-25.44%
-26.87
-12.96%
-23.79
-32.70%
-17.93
Interest Expense
25.63
+6.24%
24.12
+13.64%
21.23
+41.98%
14.95
Other Income Expense
-23.10
-277.71%
-6.12
+40.81%
-10.33
+15.50%
-12.23
Other Non Operating Income Expenses
-0.98
+61.46%
-2.53
-333.28%
1.08
+127.85%
-3.90
Gain On Sale Of Security
-22.04
-129.28%
-9.61
+18.05%
-11.73
-23.11%
-9.53
Tax Provision
1.27
-66.29%
3.78
+453.59%
-1.07
-105.95%
17.97
Tax Rate For Calcs
0.00
+2.52%
0.00
-2.45%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-7.35
-181.97%
-2.61
+40.97%
-4.42
-33.12%
-3.32
Net Income Including Noncontrolling Interests
-58.85
-907.32%
7.29
-63.87%
20.17
+616.12%
-3.91
Net Income From Continuing Operation Net Minority Interest
-55.42
-1396.07%
4.28
-77.23%
18.78
+360.85%
-7.20
Net Income From Continuing And Discontinued Operation
-55.42
-1396.07%
4.28
-77.23%
18.78
+360.85%
-7.20
Net Income Continuous Operations
-58.85
-907.32%
7.29
-63.87%
20.17
+616.12%
-3.91
Minority Interests
3.43
+213.80%
-3.01
-116.05%
-1.39
+57.62%
-3.29
Normalized Income
-41.77
-548.92%
9.30
-65.52%
26.98
+2697.27%
-1.04
Net Income Common Stockholders
-55.42
-1396.07%
4.28
-77.23%
18.78
+360.85%
-7.20
Diluted EPS
-0.83
-1722.53%
0.05
-82.81%
0.30
+274.62%
-0.17
Basic EPS
-0.83
-1706.81%
0.05
-82.93%
0.30
+277.56%
-0.17
Basic Average Shares
63.20
+0.57%
62.84
+1.12%
62.15
+46.91%
42.30
Diluted Average Shares
63.20
-0.45%
63.49
+0.47%
63.19
+49.37%
42.30
Diluted NI Availto Com Stockholders
-55.42
-1396.07%
4.28
-77.23%
18.78
+360.85%
-7.20
Amortization
5.72
-3.81%
5.95
-1.06%
6.01
+267.84%
1.63
Amortization Of Intangibles Income Statement
5.72
-3.81%
5.95
-1.06%
6.01
+267.84%
1.63
Depreciation Amortization Depletion Income Statement
10.59
+3.99%
10.18
-8.57%
11.14
+137.25%
4.69
Depreciation And Amortization In Income Statement
10.59
+3.99%
10.18
-8.57%
11.14
+137.25%
4.69
Depreciation Income Statement
4.87
+14.96%
4.23
-17.38%
5.12
+67.47%
3.06
Earnings From Equity Interest
-1.13
-127.81%
4.05
+237.85%
1.20
+4.74%
1.14
Gain On Sale Of PPE
7.75
0.00
0.00
Insurance And Claims
2.85
+34.44%
2.12
-29.58%
3.01
+85.47%
1.62
Other Taxes
12.27
-13.48%
14.18
+22.99%
11.53
+8.08%
10.67
Total Other Finance Cost
8.08
+194.11%
2.75
+7.37%
2.56
-13.95%
2.97
Line Item Trend 2025-06-30 2024-06-30 2021-06-30
Total Assets
763.65
-10.43%
852.55
Current Assets
308.31
-24.56%
408.67
Cash Cash Equivalents And Short Term Investments
34.74
-38.16%
56.17
Cash And Cash Equivalents
32.70
-26.48%
44.47
Cash Equivalents
13.21
-32.27%
19.50
Cash Financial
19.49
-21.96%
24.97
Other Short Term Investments
2.04
-82.56%
11.70
Receivables
177.75
-17.72%
216.03
Accounts Receivable
165.86
-20.00%
207.32
Gross Accounts Receivable
180.42
-16.96%
217.28
Allowance For Doubtful Accounts Receivable
-14.56
-46.24%
-9.96
Other Receivables
0.87
-69.38%
2.83
Taxes Receivable
10.75
+89.40%
5.68
Loans Receivable
0.23
Inventory
89.99
-28.71%
126.22
Raw Materials
24.60
-13.71%
28.51
Finished Goods
66.51
-33.82%
100.50
Prepaid Assets
5.83
-43.04%
10.24
Restricted Cash
0.00
-100.00%
0.43
Total Non Current Assets
455.33
+2.58%
443.88
Net PPE
90.95
+5.54%
86.18
Gross PPE
104.72
+9.59%
95.55
Accumulated Depreciation
-13.77
-46.78%
-9.38
Properties
39.08
-1.52%
39.68
Machinery Furniture Equipment
18.64
-17.57%
22.61
Construction In Progress
16.86
+37.28%
12.28
Other Properties
30.14
+43.68%
20.98
Goodwill And Other Intangible Assets
293.34
+1.48%
289.06
Goodwill
112.16
+0.00%
112.16
Other Intangible Assets
181.17
+2.42%
176.89
Investments And Advances
39.37
-2.60%
40.42
Long Term Equity Investment
39.37
-1.04%
39.79
Other Investments
Non Current Accounts Receivable
25.96
+46.33%
17.74
Non Current Deferred Assets
4.92
-49.30%
9.70
Non Current Deferred Taxes Assets
4.92
-49.30%
9.70
Total Liabilities Net Minority Interest
468.43
-6.53%
501.17
Current Liabilities
337.99
+2.63%
329.31
Payables And Accrued Expenses
96.89
-44.18%
173.56
Payables
96.89
-44.18%
173.56
Accounts Payable
91.58
-43.44%
161.93
Other Payable
1.29
+14.56%
1.12
Employee Benefits
0.00
Pensionand Other Post Retirement Benefit Plans Current
6.17
-15.90%
7.34
Total Tax Payable
3.74
-64.32%
10.47
Income Tax Payable
0.45
-90.62%
4.83
Current Debt And Capital Lease Obligation
228.88
+63.64%
139.87
Current Debt
222.00
+62.34%
136.75
Other Current Borrowings
222.00
+62.34%
136.75
Current Capital Lease Obligation
6.88
+120.45%
3.12
Current Deferred Liabilities
4.28
+9.16%
3.92
Current Deferred Revenue
4.28
+9.16%
3.92
Other Current Liabilities
1.76
-61.85%
4.62
Total Non Current Liabilities Net Minority Interest
130.44
-24.10%
171.86
Long Term Debt And Capital Lease Obligation
47.73
-63.59%
131.08
Long Term Debt
38.20
-68.92%
122.91
Long Term Capital Lease Obligation
9.53
+16.74%
8.16
Long Term Provisions
1.27
+0.95%
1.26
Tradeand Other Payables Non Current
48.48
0.00
Non Current Deferred Liabilities
31.56
-14.52%
36.92
Non Current Deferred Revenue
1.44
-25.36%
1.93
Non Current Deferred Taxes Liabilities
30.12
-13.92%
35.00
Other Non Current Liabilities
0.40
-82.77%
2.31
Stockholders Equity
262.81
-16.65%
315.30
Common Stock Equity
262.81
-16.65%
315.30
Capital Stock
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
Share Issued
65.63
+4.43%
62.85
Ordinary Shares Number
63.23
+4.35%
60.59
Treasury Shares Number
2.40
+6.41%
2.26
+386.16%
0.46
Additional Paid In Capital
329.22
+0.72%
326.86
Retained Earnings
-65.04
-575.61%
-9.63
Gains Losses Not Affecting Retained Earnings
0.09
-85.51%
0.63
Treasury Stock
32.21
+2.96%
31.29
Minority Interest
32.41
-10.18%
36.08
Total Equity Gross Minority Interest
295.22
-15.98%
351.38
Total Capitalization
301.01
-31.31%
438.21
Working Capital
-29.67
-137.39%
79.36
Invested Capital
523.01
-9.04%
574.96
Total Debt
276.61
+2.09%
270.95
Net Debt
227.50
+5.72%
215.19
Capital Lease Obligations
16.41
+45.44%
11.28
Net Tangible Assets
-30.53
-216.34%
26.24
Tangible Book Value
-30.53
-216.34%
26.24
Available For Sale Securities
0.00
-99.99%
0.63
Derivative Product Liabilities
0.00
Duefrom Related Parties Current
0.28
+33.55%
0.21
Duefrom Related Parties Non Current
21.65
+39.69%
15.50
Dueto Related Parties Current
0.29
+653.38%
0.04
Dueto Related Parties Non Current
1.01
+239.91%
0.30
Fixed Assets Revaluation Reserve
-0.16
+0.00%
-0.16
Foreign Currency Translation Adjustments
0.25
-68.21%
0.79
Inventories Adjustments Allowances
-3.51
-13.57%
-3.09
Investment Properties
0.57
+1.70%
0.56
Investmentin Financial Assets
0.00
-99.99%
0.63
Line Of Credit
0.03
Non Current Note Receivables
0.23
+0.00%
0.23
Other Equity Interest
30.75
+7.09%
28.71
Other Inventories
2.38
+708.60%
0.29
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
49.91
+19.63%
41.72
+1511.43%
2.59
+114.78%
-17.52
Cash Flow From Continuing Operating Activities
49.91
+19.63%
41.72
+1511.43%
2.59
+114.78%
-17.52
Net Income From Continuing Operations
-58.85
-907.32%
7.29
-63.87%
20.17
+616.12%
-3.91
Depreciation Amortization Depletion
22.18
+4.16%
21.30
+9.82%
19.39
+111.04%
9.19
Depreciation
11.03
+20.10%
9.18
+9.32%
8.40
+67.10%
5.03
Amortization Cash Flow
11.15
-7.91%
12.11
+10.20%
10.99
+164.13%
4.16
Depreciation And Amortization
22.18
+4.16%
21.30
+9.82%
19.39
+111.04%
9.19
Amortization Of Intangibles
11.15
-7.91%
12.11
+10.20%
10.99
+164.13%
4.16
Other Non Cash Items
59.10
+58.44%
37.30
-13.25%
43.00
+110.46%
20.43
Stock Based Compensation
4.39
-68.97%
14.13
+313.89%
3.42
+138.69%
1.43
Provisionand Write Offof Assets
9.01
+427.64%
1.71
-34.72%
2.62
-4.57%
2.74
Deferred Tax
1.27
-66.29%
3.78
+453.59%
-1.07
-105.95%
17.97
Deferred Income Tax
1.27
-66.29%
3.78
+453.59%
-1.07
-105.95%
17.97
Operating Gains Losses
-6.62
-58.68%
-4.17
-266.18%
-1.14
+63.09%
-3.09
Gain Loss On Sale Of PPE
-7.75
-6078.12%
-0.13
-68.20%
-0.07
+96.16%
-1.94
Change In Working Capital
19.30
+146.50%
-41.51
+51.23%
-85.11
-39.86%
-60.85
Change In Receivables
24.58
+147.60%
-51.65
+24.43%
-68.34
-111.79%
-32.27
Changes In Account Receivables
25.50
+154.62%
-46.68
+17.91%
-56.87
-127.73%
-24.97
Change In Inventory
34.91
+146.25%
14.18
+228.10%
-11.07
+79.99%
-55.31
Change In Payables And Accrued Expense
-32.04
-325.09%
14.23
+416.21%
-4.50
-108.42%
53.48
Change In Payable
-32.04
-325.09%
14.23
+416.21%
-4.50
-108.42%
53.48
Change In Account Payable
-4.50
-108.42%
53.48
Change In Other Working Capital
-8.15
+55.38%
-18.27
-1427.80%
-1.20
+95.53%
-26.75
Change In Other Current Liabilities
0.00
+100.00%
-0.00
Investing Cash Flow
-6.13
+78.67%
-28.73
-11.67%
-25.73
-986.15%
2.90
Cash Flow From Continuing Investing Activities
-6.13
+78.67%
-28.73
-11.67%
-25.73
-986.15%
2.90
Net PPE Purchase And Sale
-5.25
+44.44%
-9.45
+15.77%
-11.22
-694.83%
-1.41
Purchase Of PPE
-5.64
+42.37%
-9.79
+13.83%
-11.36
-228.45%
-3.46
Sale Of PPE
0.39
+15.93%
0.34
+145.15%
0.14
-93.29%
2.05
Capital Expenditure
-14.61
+35.88%
-22.78
-0.97%
-22.56
-150.77%
-9.00
Capital Expenditure Reported
-8.61
+27.34%
-11.86
-10.25%
-10.75
-108.81%
-5.15
Net Investment Purchase And Sale
8.09
+227.98%
-6.32
+17.63%
-7.67
-174.67%
10.28
Purchase Of Investment
-11.18
-55.13%
-7.21
+19.82%
-8.99
-337.29%
-2.06
Sale Of Investment
19.27
+2069.74%
0.89
-32.56%
1.32
-89.32%
12.33
Net Business Purchase And Sale
0.00
-100.00%
0.04
-99.14%
4.37
0.00
Purchase Of Business
0.00
0.00
Gain Loss On Sale Of Business
Net Intangibles Purchase And Sale
-0.35
+69.15%
-1.14
-152.87%
-0.45
-15.59%
-0.39
Purchase Of Intangibles
-0.35
+69.15%
-1.14
-152.87%
-0.45
-15.59%
-0.39
Net Other Investing Changes
-0.42
Financing Cash Flow
-50.71
-404.24%
-10.06
-130.51%
32.95
+122.31%
14.82
Cash Flow From Continuing Financing Activities
-50.71
-404.24%
-10.06
-130.51%
32.95
+122.31%
14.82
Net Issuance Payments Of Debt
-27.57
-250.43%
18.32
-69.06%
59.22
+106.06%
28.74
Issuance Of Debt
266.39
+96.14%
135.82
+70.16%
79.82
-43.16%
140.43
Repayment Of Debt
-293.96
-150.19%
-117.49
-470.34%
-20.60
+81.56%
-111.69
Long Term Debt Issuance
266.39
+96.14%
135.82
+70.16%
79.82
-43.16%
140.43
Long Term Debt Payments
-293.96
-150.19%
-117.49
-470.34%
-20.60
+81.55%
-111.66
Net Long Term Debt Issuance
-27.57
-250.43%
18.32
-69.06%
59.22
+105.82%
28.77
Short Term Debt Payments
0.00
0.00
+100.00%
-0.03
Net Short Term Debt Issuance
0.00
0.00
+100.00%
-0.03
Net Common Stock Issuance
-0.93
-26.21%
-0.73
+75.50%
-3.00
0.00
Common Stock Payments
-0.93
-26.21%
-0.73
+75.50%
-3.00
0.00
Cash Dividends Paid
0.00
0.00
0.00
0.00
Repurchase Of Capital Stock
-0.93
-26.21%
-0.73
+75.50%
-3.00
0.00
Proceeds From Stock Option Exercised
0.00
0.00
Net Other Financing Charges
-3.28
-12.30%
-2.92
+44.02%
-5.22
-476.76%
-0.90
Changes In Cash
-6.93
-336.30%
2.93
-70.13%
9.82
+4547.95%
0.21
Effect Of Exchange Rate Changes
-4.85
+26.01%
-6.56
-232.76%
4.94
-27.83%
6.84
Beginning Cash Position
44.47
-7.60%
48.13
+43.78%
33.48
-7.13%
36.05
End Cash Position
32.70
-26.48%
44.47
-7.60%
48.13
+43.78%
33.48
Free Cash Flow
35.30
+86.43%
18.93
+194.79%
-19.97
+24.66%
-26.51
Change In Income Tax Payable
-16.15
-349.68%
6.47
Change In Tax Payable
-16.15
-349.68%
6.47
Earnings Losses From Equity Investments
1.13
+127.81%
-4.05
-280.04%
-1.07
+6.89%
-1.14
Interest Paid CFF
-18.93
+23.43%
-24.72
-37.00%
-18.05
-38.72%
-13.01
Interest Received CFO
0.12
-95.61%
2.75
-48.92%
5.38
-4.45%
5.63
Other Cash Adjustment Outside Changein Cash
0.00
+108.01%
-0.03
+68.64%
-0.10
+98.94%
-9.62
Sale Of Business
0.00
-100.00%
0.04
-99.14%
4.37
0.00
Taxes Refund Paid
0.00
+100.00%
-0.85
+79.05%
-4.07
+42.31%
-7.06
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category